Professional Documents
Culture Documents
• Related Articles
Introduction
In 1971, Robert Machemer introduced pars plana vitrectomy for ophthalmologic surgeries
(Machemeret al., 1971). Since then, the progress in biomedical engineering has led to the
invention of small gauge vitrectomy, which is considered minimally invasive
vitreous surgery (MIVS). As studies have been reported in the past, MIVS can be done by
various approaches, for example, the 25-G sutureless transconjunctival vitrectomy system
(TCVS) introduced by Fujii et al. (2002), 23-G sutureless vitrectomy system introduced by
Eckardt (2005), and the 27-G sutureless transconjunctival vitrectomy system introduced by
Oshima et al. (2010). With advances in such surgical techniques and instrumentation, vitrectomy
has become a common surgical procedure for posterior segment disorders such as non-clearing
vitreous hemorrhage due to diabetic retinopathy or vein occlusions, retinal detachment, macular
hole, macular pucker, vitreomacular traction, tractional macular edema, and others. However,
like all other surgeries, vitrectomy also has some early and late complications. Early
complications include a rise in intraocular pressure (IOP), cannula retraction, retinal break
formation, hypotony, retinal toxicity, etc., and late complications include formation or acceleration
of NSC in phakic eyes (Cherfan et al., 1991; de Bustros et al., 1988; Khanduja et al., 2013). NSC
is the most common cause of the postoperative decrease in visual acuity after successful
treatment of the disease. This limits the visual acuity, which further requires surgical correction.
The preferred method of surgery to correct NSC is phacoemulsification and intraocular lens
implantation. This surgery has two challenging features: (1) hardening of the nucleus as
compared to the age-related nuclear sclerosis, which requires a longer phacoemulsification time
during the procedure, and (2) more mobility of the posterior capsule due to the absence of
vitreous in the posterior segment, which increases the risk of capsular rupture. Thus, surgery for
post-vitrectomy NSC may have a higher probability of complications (Do et al., 2008). The
purpose of the present review is to summarize the hypotheses proposed by different authors in
their studies and possible measures that are known so far to prevent post-vitrectomy NSC along
with its treatment and its complications. Moreover, we aim to describe the pathophysiology of the
formation of post-vitrectomy NSC.
Pathophysiology
NSC is the increase in the stiffness of nuclear cytoplasm of the lens that causes lens
opacification. The mechanism of development of post-vitrectomy NSC is still unclear. To prevent
NSC, a clear understanding of the pathogenic mechanisms of lens opacification is needed.
Transparency and the refractive power of the lens are maintained by a very high protein
concentration. These proteins are protected from oxidation by the low-oxygen environment
around the lens with the help of reducing substances, like glutathione (GSH) and ascorbate
(Beebe et al., 2011). Oxygen levels in the eye are generally low and tightly regulated. In the
normal eye, much of the oxygen is metabolized by the adjacent retinal tissue and molecular
oxygen diffuses into the vitreous gel from the retinal vasculature(Alder et al., 1986), while some
are consumed by reacting with ascorbate in the vitreous gel (Beebe et al., 2014′; Shui et al.,
2009) decreasing the oxygen gradient from the retina to the lens. Thus, oxygen consumption by
the vitreous assures that the crystalline lens remains in a low oxygen environment, which is
thought to be an important factor for the maintenance of lens transparency (Eaton, 1991). The
concentration of antioxidant molecules, such as glutathione, is lowest in the nucleus and highest
on the lens surface (Sweeney et al., 2003). With increasing age and exposure of lenses to
hyperbaric oxygen, glutathione levels markedly decrease in the nucleus, making the nucleus of
the lens sensitive to oxidative insult and resulting in cataract formation (Beebe et al., 2011). A
study (Shui et al., 2009) has demonstrated that ascorbate levels were significantly lower in eyes
with increased vitreous liquefaction or previous vitrectomy, due to a greater mixing of the vitreous
fluid with oxygen, degrading a larger portion of the ascorbate. Therefore, loss of the vitreous gel
structure correlated with loss of vitreous function. According to Calvin et al. (1991), information
about the role of GSH in maintaining lens transparency was found in the intact lens when an
experimental depletion of glutathione by L-buthionine-(S,R)-sulfoximine (BSO), an inhibitor of
GSH biosynthesis, leads to a rapid cataract formation. The lens is an avascular tissue which
depends on diffusion from the retina for its oxygen supply, so elevated oxygen tension in the
vitreous leads to elevated oxygen tension in the crystalline lens which may play a key role in
NSC (Barbazetto et al., 2004). In a normal individual, there is a concentration gradient of oxygen
from the retina into the vitreous gel, when the vitreous gel is intact. If vitreous gel liquefies with
age or is removed by vitrectomy surgery, vitreous fluid can circulate delivering more oxygen to
the lens (Harocopos et al., 2004). A study (Holekamp et al., 2005) has shown an increased
oxygen level in the lens after vitrectomy, which leads to acceleration of NSC (Cherfan et al.,
1991; de Bustros et al., 1988; Margherio et al., 1985; Melberg and Thomas, 1995; Ogura et al.,
1991; Thompson et al., 1995). The incidence of NSC progression is greater in older patients
(Cherfan et al., 1991; Melberg and Thomas, 1995; Novak et al., 1984; Ogura et al., 1991), and
risk increases due to the loss of vitreous gel (Harocopos et al., 2004), as the liquefied vitreous
fluid has a diminished capacity to consume oxygen (Shui et al., 2009). The decrease in
antioxidants such as GSH and ascorbate (Giblin et al., 1995), the oxidation of nuclear proteins at
the center of the crystalline lens (Giblin et al., 1995), and the accumulation of insoluble lens
proteins and pigments (Spector, 1984) are some factors that result in loss of transparency of
the aging lens. When nuclear sclerosis occurs due to aging, it usually develops bilaterally, as
compared to operating eyes that progress unilaterally. Inhaled oxygen concentration influences
oxygen concentration of vitreous gel, as inhaling large percentages of oxygen while receiving
general anesthesia or previous vitrectomy surgery significantly increased intraocular oxygen
tension (Holekamp et al., 2005). While using long-term hyperbaric oxygen therapy, nearly 50% of
patients developed a nuclear cataract in 1 to 3 years. The cataractogenic effect of hyperbaric
oxygen in humans (Palmquist et al., 1984), mice (Schocket et al., 1972), and older guinea pigs
(Giblin et al., 1995) was observed as there was a rapid development of NSC in those who were
exposed to hyperbaric oxygen, which strongly supports the oxidative theory of NSC formation.
Myopia is known to have a higher prevalence of nuclear cataract but the mechanism is not yet
clear. Holekamp et al. (2008) suggested that it is related to the early vitreous degeneration that
accompanies axial elongation. Still, other authors found that patients with high myopia tend to
have vitreous liquefaction and the development of NSC (Bishop, 2000; Morita et al., 1995).
Hypothesis
A number of hypotheses have been postulated regarding the mechanism of the development of
post-vitrectomy NSC, yet it is not clear. Similarly, various preventive measures have been taken
to prevent post-vitrectomy NSC without satisfying results. Multiple factors may contribute to the
development and progression of post-vitrectomy NSC which includes the following.
Acknowledgment
This project was supported by National Natural Science Foundation of China (No. 81700840).
Disclosure
The authors declare no conflicts of interest.
Corresponding Author
Prof. Fang Wang, M.D., Ph.D., Department of Ophthalmology, Shanghai Tenth People’s Hospital
Affiliated to Tongji University School of Medicine, 301 Middle Yan Chang Rd., Shanghai 200072,
China.
References
Age-Related Eye Disease Study Research Group. Risk factors associated with age-related
nuclear and cortical cataract: a case-control study in the Age-Related Eye Disease Study,
AREDS Report No. 5. Ophthalmology 108(8):1400-1408, 2001.
Alder VA, Cringle SJ. The effect of the retinal circulation on vitreal oxygen tension. Curr Eye
Res4(2):121-129, 1985.
Alder VA, Niemeyer G, Cringle SJ, Brown MJ. Vitreal oxygen tension gradients in the isolated
perfused cat eye. Curr Eye Res 5(4):249-256, 1986.
Almony A, Holekamp NM, Bai F, Shui YB, Beebe D. Small-gauge vitrectomy does not protect
against nuclear sclerotic cataract. Retina 32(3):499-505, 2012.
Barbazetto IA, Liang J, Chang S, Zheng L, Spector A, Dillon JP. Oxygen tension in the rabbit
lens and vitreous before and after vitrectomy. Exp Eye Res 78(5):917-924, 2004.
Beebe DC, Holekamp NM, Siegfried C, Shui YB. Vitreoretinal influences on lens function and
cataract. Philosophical Transactions of the Royal Society of London. Series B, Biological
Sciences366(1568):1293-1300, 2011.
Beebe DC, Shui YB, Siegfried CJ, Holekamp NM, Bai F. Preserve the (intraocular) environment:
the importance of maintaining normal oxygen gradients in the eye. Jpn J Ophthalmol 58(3):225-
231, 2014.
Bishop PN. Structural macromolecules and supramolecular organisation of the vitreous gel. Prog
Retin Eye Res 19(3):323-344, 2000.
Calvin HI, Medvedovsky C, David JC, Broglio TM, Hess JL, Fu SC, Worgul
BV. Rapid deterioration of lens fibers in GSH-depleted mouse pups. Invest Ophthalmol Vis
Sci 32(6):1916-1924, 1991.
Cheng L, Azen SP, El-Bradey MH, Scholz BM, Chaidhawangul S, Toyoguchi M, Freeman WR.
Duration of vitrectomy and postoperative cataract in the vitrectomy for macular hole study. Am J
Ophthalmol 132(6):881-887, 2001.
Cherfan GM, Michels RG, De Bustros S, Enger C, Glaser BM. Nuclear sclerotic cataract after
vitrectomy for idiopathic epiretinal membranes causing macular pucker. Am J
Ophthalmol 111(4):434-438, 1991.
De Bustros S, Thompson JT, Michels RG, Enger C, Rice TA, Glaser BM. Nuclear sclerosis after
vitrectomy for idiopathic epiretinal membranes. Am J Ophthalmol 105(2):160-164, 1988.
Diaz Lacalle V, Orbegozo Garate FJ, Martinez Alday N, Lopez Garrido JA, Aramberri Agesta J.
Phacoemulsification cataract surgery in vitrectomized eyes. J Cataract Refract Surg 24(6):806-
809, 1998.
Do DV, Hawkins B, Gichuhi S, Vedula SS. Surgery for post-vitrectomy cataract. Cochrane
Database Syst Rev (3):Cd006366, 2008.
Eaton JW. Is the lens canned? Free Radic Biol Med 11(2):207-213, 1991.
Eckardt C. Transconjunctival sutureless 23-gauge vitrectomy. Retina 25(2):208-211, 2005.
Edelhauser HF, Gonnering R, Van Horn DL. Intraocular irrigating solutions. A comparative study
of BSS Plus and lactated Ringer’s solution. Archives of ophthalmology (Chicago, Ill.:
1960) 96(3):516-520, 1978.
Fecondo JV, Augusteyn RC. Superoxide dismutase, catalase and glutathione peroxidase in the
human cataractous lens. Experimental eye research 36(1):15-23, 1983.
Fujii GY, De Juan E, Jr., Humayun MS, Pieramici DJ, Chang TS, Awh C, Ng E, Barnes A, Wu
SL, Sommerville DN. A new 25-gauge instrument system for transconjunctival sutureless
vitrectomy surgery. Ophthalmology 109(10):1807-1812; discussion 1813, 2002.
Garland DL. Ascorbic acid and the eye. American journal of clinical nutrition 54(6 Suppl):1198s-
1202s, 1991.
Giblin FJ, Padgaonkar VA, Leverenz VR, Lin LR, Lou MF, Unakar NJ, Dang L, Dickerson JE, Jr.,
Reddy VN. Nuclear light scattering, disulfide formation and membrane damage in lenses of older
guinea pigs treated with hyperbaric oxygen. Experimental eye research 60(3):219-235, 1995.
Grewing R, Mester U. Results of surgery for epiretinal membranes and their recurrences. British
journal of ophthalmology 80(4):323-326, 1996.
Grusha YO, Masket S, Miller KM. Phacoemulsification and lens implantation after pars plana
vitrectomy. Ophthalmology 105(2):287-294, 1998.
Harocopos GJ, Shui YB, Mckinnon M, Holekamp NM, Gordon MO, Beebe DC. Importance of
vitreous liquefaction in age-related cataract. Invest Ophthalmol Vis Sci 45(1):77-85, 2004.
Holekamp NM, Bai F, Shui YB, Almony A, Beebe DC. Ischemic diabetic retinopathy may protect
against nuclear sclerotic cataract. American journal of ophthalmology 150(4):543-550.e541,
2010.
Holekamp NM, Harocopos GJ, Shui YB, Beebe DC. Myopia and axial length contribute to
vitreous liquefaction and nuclear cataract. Archives of ophthalmology (Chicago, Ill.:
1960) 126(5):744; author reply 744, 2008.
Holekamp NM, Shui YB, Beebe D. Lower intraocular oxygen tension in diabetic patients:
possible contribution to decreased incidence of nuclear sclerotic cataract. American journal of
ophthalmology141(6):1027-1032, 2006.
Holekamp NM, Shui YB, Beebe DC. Vitrectomy surgery increases oxygen exposure to the lens:
a possible mechanism for nuclear cataract formation. American journal of
ophthalmology 139(2):302-310, 2005.
Hsuan JD, Brown NA, Bron AJ, Patel CK, Rosen PH. Posterior subcapsular and nuclear cataract
after vitrectomy. Journal of cataract and refractive surgery 27(3):437-444, 2001.
Hutton WL, Pesicka GA, Fuller DG. Cataract extraction in the diabetic eye after
vitrectomy. American journal of ophthalmology 104(1):1-4, 1987.
Khanduja S, Kakkar A, Majumdar S, Vohra R, Garg S. Small gauge vitrectomy: Recent
update. Oman journal of ophthalmology 6(1):3-11, 2013.
Machemer R, Buettner H, Norton EW, Parel JM. Vitrectomy: a pars plana approach. American
Academy of Ophthalmology and Otolaryngology 75(4):813-820, 1971.
Margherio RR, Cox MS, Jr., Trese MT, Murphy PL, Johnson J, Minor LA. Removal of epimacular
membranes. Ophthalmology 92(8):1075-1083, 1985.
Mcdermott ML, Puklin JE, Abrams GW, Eliott D. Phacoemulsification for cataract following pars
plana vitrectomy. Ophthalmic surgery and lasers 28(7):558-564, 1997.
Melberg NS, Thomas MA. Nuclear sclerotic cataract after vitrectomy in patients younger than 50
years of age. Ophthalmology 102(10):1466-1471, 1995.
Mitchell Rl AI. Catalase photoinactivation [report]. Science 150:74, 1965.
Morita H, Funata M, Tokoro T. A clinical study of the development of posterior vitreous
detachment in high myopia. Retina 15(2):117-124, 1995.
Novak MA, Rice TA, Michels RG, Auer C. The crystalline lens after vitrectomy for diabetic
retinopathy. Ophthalmology 91(12):1480-1484, 1984.
Ogura Y, Takanashi T, Ishigooka H, Ogino N. Quantitative analysis of lens changes after
vitrectomy by fluorophotometry. American journal of ophthalmology 111(2):179-183, 1991.
Oshima Y, Wakabayashi T, Sato T, Ohji M, Tano Y. A 27-gauge instrument system for
transconjunctival sutureless microincision vitrectomy surgery. Ophthalmology 117(1):93-
102.e102, 2010.
Palmquist BM, Philipson B, Barr PO. Nuclear cataract and myopia during hyperbaric oxygen
therapy. British journal of ophthalmology 68(2):113-117, 1984.
Patel AS, Miller KM. Cataract surgery after retinal surgery. Current opinion in
ophthalmology12(3):196-201, 2001.
Petermeier K, Szurman P, Bartz-Schmidt UK, Gekeler F. [Pathophysiology of cataract formation
after vitrectomy]. Klinische Monatsblatter fur Augenheilkunde 227(3):175-180, 2010.
Rose RC, Richer SP, Bode AM. Ocular oxidants and antioxidant protection. Proceedings of the
Society for Experimental Biology and Medicine (New York, N.Y.) 217(4):397-407, 1998.
Saito Y, Lewis JM, Park I, Ikuno Y, Hayashi A, Ohji M, Tano Y. Nonvitrectomizing vitreous
surgery: a strategy to prevent postoperative nuclear sclerosis. Ophthalmology 106(8):1541-1545,
1999.
Sawa M, Ohji M, Kusaka S, Sakaguchi H, Gomi F, Saito Y, Tano Y. Nonvitrectomizing vitreous
surgery for epiretinal membrane long-term follow-up. Ophthalmology 112(8):1402-1408, 2005.
Sawa M, Saito Y, Hayashi A, Kusaka S, Ohji M, Tano Y. Assessment of nuclear sclerosis after
nonvitrectomizing vitreous surgery. American journal of ophthalmology 132(3):356-362, 2001.
Schocket SS, Esterson J, Bradford B, Michaelis M, Richards RD. Induction of cataracts in mice
by exposure to oxygen. Israel journal of medical sciences 8(8):1596-1601, 1972.
Shui YB, Holekamp NM, Kramer BC, Crowley JR, Wilkins MA, Chu F, Malone PE, Mangers SJ,
Hou JH, Siegfried CJ, Beebe DC. The gel state of the vitreous and ascorbate-dependent oxygen
consumption: relationship to the etiology of nuclear cataracts. Archives of ophthalmology
(Chicago, Ill.: 1960) 127(4):475-482, 2009.
Smiddy WE, Feuer W. Incidence of cataract extraction after diabetic
vitrectomy. Retina 24(4):574-581, 2004.
Sneed S, Parrish RK, 2nd, Mandelbaum S, O’Grady G. Technical problems of extracapsular
cataract extractions after vitrectomy. Archives of ophthalmology (Chicago, Ill.:
1960) 104(8):1126-1127, 1986.
Spector A. The search for a solution to senile cataracts. Proctor lecture. Invest Ophthalmol Vis
Sci25(2):130-146, 1984.
Stevens VJ, Rouzer CA, Monnier VM, Cerami A. Diabetic cataract formation: potential role of
glycosylation of lens crystallins. Proc Natl Acad Sci U S A 75(6):2918-2922, 1978.
Sweeney MH, Garland DL, Truscott RJ. Movement of cysteine in intact monkey lenses: the
major site of entry is the germinative region. Experimental eye research 77(2):245-251, 2003.
Thompson JT. The role of patient age and intraocular gases in cataract progression following
vitrectomy for macular holes and epiretinal membranes. Transactions of the American
Ophthalmological Society 101:485-498, 2003.
Thompson JT, Glaser BM, Sjaarda RN, Murphy RP. Progression of nuclear sclerosis and long-
term visual results of vitrectomy with transforming growth factor beta-2 for macular
holes. American journal of ophthalmology 119(1):48-54, 1995.
Titiyal JS, Agarwal E, Angmo D, Sharma N, Kumar A. Comparative evaluation of outcomes of
phacoemulsification in vitrectomized eyes: silicone oil versus air/gas group. International
ophthalmology 37(3):565-574, 2017.
Van Effenterre G, Ameline B, Campinchi F, Quesnot S, Le Mer Y, Haut J. [Is vitrectomy
cataractogenic? Study of changes of the crystalline lens after surgery of retinal
detachment]. Journal francais d’ophtalmologie 15(8-9):449-454, 1992.
Wong SC, Clare G, Bunce C, Sullivan PM, Gregor ZJ, Ezra E. Cataract progression in macular
hole cases: results with vitrectomy or with observation. Journal of cataract and refractive
surgery38(7):1176-1180, 2012.
[Discovery Medicine; ISSN: 1539-6509; Discov Med 24(134):305-311, December
2017. Copyright © Discovery Medicine. All rights reserved.]
Related Articles
• Jun 27, 2017 Anti-fibrosis Effect of Nanoparticle-mediated Delivery of Plasminogen Kringle 5
• May 29, 2017 The Role of Netrin-1 in Angiogenesis and Diabetic Retinopathy: a Promising
Therapeutic Strategy
• Feb 19, 2017 Salvianolic Acid A Protects Retinal Pigment Epithelium from OX-LDL-induced
Inflammation in an Age-Related Macular Degeneration Model
• Dec 17, 2016 An Emerging Role of Alu RNA in Geographic Atrophy Pathogenesis: the Implication for
Novel Therapeutic Strategies
• Nov 21, 2016 The Role of Connexin43 in Diabetic Microvascular Complications
• Oct 25, 2016 Gene Therapy Approaches for the Treatment of Retinal Disorders
• Sep 19, 2016 Association of Lipids with Age-related Macular Degeneration
• May 22, 2016 Therapeutic Effects of a Novel PIGF-1 Derived Peptide, ZY-1, on Corneal
Neovascularization In Vitro and In Vivo
• Apr 26, 2016 The Emerging Roles of Clusterin in Reduction of Both Blood Retina Barrier Breakdown
and Neural Retina Damage in Diabetic Retinopathy
• Mar 27, 2016 Detecting A-beta Deposition and RPE Cell Senescence in the Retinas of SAMP8 Mice
• More Related Articles